title: Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.
authors.affiliation: *Department of Medicine, University of California, San Diego, CA †Department of Family Medicine and Public Health, University of California, San Diego, CA ‡Kaiser Permanente, San Diego, CA §Scripps Health San Diego, San Diego, CA ‖Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA ¶Desert Regional Medical Center, Palm Springs, CA #Santa Clara Valley Medical Center, San Jose, CA **University California Irvine, Irvine, CA ††Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center and the David Geffen School of Medicine at UCLA, Los Angeles, CA ‡‡Gilead Sciences, Foster City, CA.
authors.forename: Maile Y
authors.initials: MY
authors.lastname: Karris
authors.forename: Sonia
authors.initials: S
authors.lastname: Jain
authors.forename: Vi Q
authors.initials: VQ
authors.lastname: Bowman
authors.forename: Gunter
authors.initials: G
authors.lastname: Rieg
authors.forename: Miguel
authors.initials: M
authors.lastname: Goicoechea
authors.forename: Michael P
authors.initials: MP
authors.lastname: Dube
authors.forename: Shubha
authors.initials: S
authors.lastname: Kerkar
authors.forename: Carol
authors.initials: C
authors.lastname: Kemper
authors.forename: Catherine
authors.initials: C
authors.lastname: Diamond
authors.forename: Xiaoying
authors.initials: X
authors.lastname: Sun
authors.forename: Eric S
authors.initials: ES
authors.lastname: Daar
authors.forename: Richard H
authors.initials: RH
authors.lastname: Haubrich
authors.forename: Sheldon
authors.initials: S
authors.lastname: Morris
mesh_terms: D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000069446:Atazanavir Sulfate / Q000627:therapeutic use; D048588:Benzoxazines / Q000627:therapeutic use; D003521:Cyclopropanes; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D000068679:Emtricitabine / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000302:isolation & purification; D000068898:Raltegravir Potassium / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use; D011795:Surveys and Questionnaires; D000068698:Tenofovir / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D061466:Lopinavir; D000068898:Raltegravir Potassium; D000069446:Atazanavir Sulfate; D000068698:Tenofovir; D000068679:Emtricitabine; C098320:efavirenz; D019438:Ritonavir